bellicum
participate
two
upcoming
virtual
conferences
houston
globe
newswire
bellicum
pharmaceuticals
nasdaq
blcm
leader
developing
novel
controllable
cellular
immunotherapies
cancers
today
announced
management
participate
two
upcoming
virtual
conferences
conference
details
jefferies
cell
therapy
virtual
summit
date
time
monday
october
edt
format
fireside
chat
virtual
cell
gene
meeting
mesa
date
monday
october
friday
october
format
prerecorded
company
presentation
available
registered
attendees
view
throughout
entirety
conference
please
visit
full
information
including
registration
live
webcast
fireside
chat
jefferies
cell
therapy
summit
may
accessed
events
presentation
section
bellicum
website
archived
version
jefferies
fireside
chat
available
replay
following
event
bellicum
pharmaceuticals
bellicum
clinical
stage
biopharmaceutical
company
striving
deliver
cures
controllable
cell
therapies
company
product
candidates
differentiated
powerful
cell
signaling
technologies
designed
produce
effective
cell
therapies
bellicum
product
candidates
designed
efficacious
cell
products
capable
overriding
key
immune
inhibitory
mechanisms
information
bellicum
found
source
bellicum
pharmaceuticals
investors
robert
uhl
managing
director
westwicke
icr
